# Effectiveness and Safety of Pigment Solution Program (PSP) as Adjuvant Therapy in Melasma

> **NCT06174545** · NA · UNKNOWN · sponsor: **Dr.dr.Irma Bernadette, SpKK (K)** · enrollment: 33 (estimated)

## Conditions studied

- Melasma

## Interventions

- **DRUG:** Pigment Solution Program

## Key facts

- **NCT ID:** NCT06174545
- **Lead sponsor:** Dr.dr.Irma Bernadette, SpKK (K)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-25
- **Primary completion:** 2023-12-18
- **Final completion:** 2023-12-31
- **Target enrollment:** 33 (ESTIMATED)
- **Last updated:** 2023-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06174545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06174545, "Effectiveness and Safety of Pigment Solution Program (PSP) as Adjuvant Therapy in Melasma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06174545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*